Cipla Ltd.
| BSE: 500087 | Sector: Health care |
| NSE: CIPLA | ISIN Code: INE059A01026 |
| BSE 00:00 | 04 Jan | 923.85 |
-6.55 (-0.70%) |
OPEN
935.00 |
HIGH
936.20 |
LOW
920.25 |
| NSE 00:00 | 04 Jan | 924.25 |
-6.25 (-0.67%) |
OPEN
937.45 |
HIGH
937.45 |
LOW
920.25 |
| OPEN | 935.00 |
| PREVIOUS CLOSE | 930.40 |
| VOLUME | 87661 |
| 52-Week high | 1005.00 |
| 52-Week low | 738.25 |
| P/E | 27.74 |
| Mkt Cap.(Rs cr) | 74,536 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
About Cipla Ltd.
Cipla Ltd is one of the leading pharmaceutical companies in India. The company focuses on development of new formulations and has a wide range of pharmaceutical products. The product portfolio includes over 1500 products across wide range of therapeutic categories.Cipla Ltd was incorporated in the year 1935 with the name Chemical Industrial & Pharmaceutical Laboratories Ltd. Khwaja Abdul Hamied th...> More
Cipla Ltd - Key Fundamentals
| Parameter | Values | ||
| Market Cap | ( cr) |
74,536 | |
| EPS - TTM | () |
[*S] | 33.30 |
| P/E Ratio | (X) | [*S] | 27.74 |
| Face Value | () |
2 | |
| Latest Dividend | (%) | 250.00 | |
| Latest Dividend Date | 09 Aug 2021 | ||
| Dividend Yield | (%) | 0.54 | |
| Book Value / Share | () |
[*S] | 261.90 |
| P/B Ratio | () |
[*S] | 3.53 |
News
-
Pharma shares trade firm; Laurus up 2%, Sun Pharma nears 52-week high
-
Cipla receives EUA for oral antiviral drug to treat mild-to-moderate Covid
-
Cipla stock rises on strong launch pipeline, FDA approval for injection
-
Cipla gains 3% on USFDA's final approval for Lanreotide injection
-
Stocks to Watch: Airtel, ICICI, Hindalco, Shriram Properties, ONGC, Cipla
Cipla Ltd - Financial Results
Particulars ( cr) |
Sep 2021 | Sep 2020 | % Chg |
| Net Sales | 5519.8 | 5038.29 | 9.56 |
| Other Income | 60.67 | 53.47 | 13.47 |
| Total Income | 5580.47 | 5091.76 | 9.6 |
| Total Expenses | 4293.6 | 3861.72 | 11.18 |
| Operating Profit | 1286.87 | 1230.04 | 4.62 |
| Net Profit | 712 | 661.85 | 7.58 |
| Equity Capital | 161.33 | 161.27 | - |
Cipla Ltd - Peer Group
| Company | Price() |
Chg (%) | Mkt Cap ( CR) |
| Sun Pharma.Inds. | 837.95 | -1.21 | 201049.34 |
| Divi's Lab. | 4621.65 | -0.69 | 122681.70 |
| Dr Reddy's Labs | 4835.70 | -0.36 | 80475.72 |
| Cipla | 923.85 | -0.70 | 74536.22 |
| Piramal Enterp. | 2677.30 | -0.31 | 63893.76 |
| Gland Pharma | 3882.60 | 0.81 | 63791.12 |
| Torrent Pharma. | 3206.45 | -1.42 | 54259.55 |
Cipla Ltd - SHAREHOLDING PATTERN
|
|
|
Promoters
Banks/FIs
FIIs
Insurance
Mutual Funds
Indian Public
Custodians
OtherCipla Ltd - Research Reports
DetailsCipla Ltd - RETURNS
| Period | BSE | NSE | Sensex | NIFTY |
| 1 Week | -1.02% | -0.97% | 3.38% | 3.32% |
| 1 Month | 1.32% | 1.34% | 3.74% | 3.54% |
| 3 Month | -3.57% | -3.47% | 0.94% | 0.64% |
| 6 Month | -5.64% | -5.61% | 14.04% | 13.25% |
| 1 Year | 11.01% | 11.05% | 24.24% | 25.98% |
| 3 Year | 79.95% | 80.24% | 67.69% | 65.98% |
Cipla Ltd - STOCK STRENGTH
| Today's Low/High | 920.25 |
|
936.20 |
| Week Low/High | 920.25 |
|
957.00 |
| Month Low/High | 850.00 |
|
957.00 |
| YEAR Low/High | 738.25 |
|
1005.00 |
| All TIME Low/High | 0.61 |
|
1005.00 |
Quick Links for Cipla:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
